{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:12Z","timestamp":1790646972087,"version":"4.1.0"},"reference-count":17,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5582\/irdr.2015.01015","type":"journal-article","created":{"date-parts":[[2016,1,31]],"date-time":"2016-01-31T22:13:36Z","timestamp":1454278416000},"page":"31-35","source":"Crossref","is-referenced-by-count":10,"title":["Using inpatient data to estimate the prevalence of Wegener's granulomatosis in China"],"prefix":"10.5582","volume":"5","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[{"name":"Shandong Medicinal Biotechnology Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Diseases of Shandong Province, Shandong Academy of Medical Sciences"},{"name":"College of Life Science and Medicine, Ji'nan University, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Cui","sequence":"additional","affiliation":[{"name":"Shandong Medicinal Biotechnology Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Diseases of Shandong Province, Shandong Academy of Medical Sciences"},{"name":"College of Life Science and Medicine, Ji'nan University, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Medicinal Biotechnology Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Diseases of Shandong Province, Shandong Academy of Medical Sciences"},{"name":"College of Life Science and Medicine, Ji'nan University, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Medicinal Biotechnology Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Diseases of Shandong Province, Shandong Academy of Medical Sciences"},{"name":"College of Life Science and Medicine, Ji'nan University, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shandong Medicinal Biotechnology Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Diseases of Shandong Province, Shandong Academy of Medical Sciences"},{"name":"College of Life Science and Medicine, Ji'nan University, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Han","sequence":"additional","affiliation":[{"name":"Shandong Medicinal Biotechnology Center, Key Laboratory for Biotech Drugs of the Ministry of Health, Key Laboratory for Rare Diseases of Shandong Province, Shandong Academy of Medical Sciences"},{"name":"College of Life Science and Medicine, Ji'nan University, Shandong Academy of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: The computational basis of DISMOD II. Popul Health Metr. 2003; 1:4.","DOI":"10.1186\/1478-7954-1-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yang LP, Liang SY, Wang XJ, Li XJ, Wu YL, Ma W. Burden of disease measured by disability-adjusted life years and a disease forecasting time deries model of scrub typhus in Laiwu, China. PLoS Negl Trop Dis. 2015; 9:e3420.","DOI":"10.1371\/journal.pntd.0003420"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chung SE, Cheong HK, Park JH, Kim HJ. Burden of disease of multiple sclerosis in Korea. Epidemiol Health. 2012; 34:e2012008.","DOI":"10.4178\/epih\/e2012008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Phanthunane P, Vos T, Whiteford H, Bertram M, Udomratn P. Schizophrenia in Thailand: Prevalence and burden of disease. Popul Health Metr. 2010; 8:24.","DOI":"10.1186\/1478-7954-8-24"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int. 2005; 68:2225-2229.","DOI":"10.1111\/j.1523-1755.2005.00679.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N. Mortality in Wegener's granulomatosis: A bimodal pattern. Rheumatology (Oxford). 2011; 50:697-702.","DOI":"10.1093\/rheumatology\/keq351"},{"key":"7","unstructured":"7. Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006; 24(2 Suppl 41):S82-91."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis: Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996; 39:87-92.","DOI":"10.1002\/art.1780390112"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tahghighi F, Moradinejad MH, Moradinejad MH, Shiari R, Raeeskarami SR, Salehzadeh F, Javadi V, Ziaee V. Evaluation of 10-year experience of Wegener's granulomatosis in Iranian children. ISRN Rheumatol. 2013; 2013:694928.","DOI":"10.1155\/2013\/694928"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Watts RA, Al-Taiar A, Scott DG, Macgregor AJ. Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database. Arthritis Rheum. 2009; 61:1412-1416.","DOI":"10.1002\/art.24544"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Villaverde-Hueso A, de la Paz MP, Martin-Arribas MC, Sanchez-Valle E, Ramirez-Gonzalez A, Biairdi P. Prevalence of scleroderma in Spain: An approach for estimating rare disease prevalence using a disease model. Pharmacoepidemiol Drug Saf. 2008; 17:1100-1107.","DOI":"10.1002\/pds.1660"},{"key":"12","unstructured":"12. Yanji Qu, Xiaolu Nie, Zhirong Yang, Siyan Zhan. Meta-analysis of the prevalence of hemophilia in mainland China. Chin J Hematol, 2014; 35:65-68. (in Chinese)"},{"key":"13","unstructured":"13. Wenbin Hu, Yonzhu Han, Renmin Yang, Nan Cheng, Benchun Xue, Daoyin Sun, Xuen Yu, Yongsheng Han, Dongqing Ye. Epidemiological investigation of hepatolenticular degeneration in the Han population of Jinzhai and Lixin counties, Anhui Province: Report of a family pedigree. Anhui Medical Journal. 2012; 33:734-737. (in Chinese)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. de la Paz MP, Villaverde-Hueso A, Alonso V, Janos S, Zurriaqa O, Pollan M, Abaitua-Borda I. Rare diseases epidemiology research. Adv Exp Med Biol. 2010; 686:17-39.","DOI":"10.1007\/978-90-481-9485-8_2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cui Y, Han J. A proposed definition of rare diseases for China: From the perspective of return on investment in new orphan drugs. Orphanet J Rare Dis. 2015; 10:28.","DOI":"10.1186\/s13023-015-0241-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cui Y, Zhao H, Liu Z, Liu C, Luan J, Zhou X, Han J. A systematic review of genetic skeletal disorders reported in Chinese biomedical journals between 1978 and 2012. Orphanet J Rare Dis. 2012; 7:55.","DOI":"10.1186\/1750-1172-7-55"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Intractable and rare diseases research in Asia. Biosci Trends. 2012; 6:48-51.","DOI":"10.5582\/bst.2012.v6.2.48"}],"container-title":["Intractable & Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/5\/1\/5_2015.01015\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:53:47Z","timestamp":1498280027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/5\/1\/5_2015.01015\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2015.01015","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}